Skip to main content

Ist die Lebertransplantation als chirurgisches Therapiekonzept bei Metastasen neuroendokriner Tumoren gerechtfertigt?

Liver Grafting for Neuroendocrine Hepatic Metastases: A Justified Therapy?

  • Conference paper
Wahrung des Bestandes, Wandel und Fortschritt der Chirurgie

Part of the book series: Langenbecks Archiv für Chirurgie ((KONGRESSBAND,volume 1996))

  • 2 Accesses

Summary

Between 1982 and February 1996 11 patients underwent liver transplantation for irresectable neuroendocrine hepatic metastases. The operative mortality was one of 11, while two patients died due to sepsis respectively tumor recurrence 7 and 68 months after transplantation. Eight patients are alive with a median survival of 55 months (range from 10 days to 8.5 years). In three patients there is no evidence of tumor and the longest disease-free survival is 102 months after LTx.

These results suggest that liver transplantation represents a justified treatment for irresectable hepatic metastases arising from neuroendocrine tumors.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literatur

  1. O’Grady JG, Poison RT, Rolles K, Calne RY, Williams R (1988) Liver transplantation for malignant disease: results in 93 consecutive patients. Ann Surg 267:373–379

    Article  Google Scholar 

  2. Pichlmayr R, Weimann A, Ringe B (1994) Indications for liver transplantation in hepatobiliary malignancy. Hepatology 20:33–40

    Google Scholar 

  3. Makowka L, Tzakis AG, Mazzaferro V, Teperman L, Demetris A, Iwatsuki S, Starzl TE (1989) Transplantation of the liver for metastatic endocrine tumors of the intestine and pancreas. Surg Gynecol Obstet 168:107–111

    CAS  PubMed Central  PubMed  Google Scholar 

  4. Arnold JC, O’Grady JG, Bird GL, Calne RY, Williams R (1989) Liver transplantation for primary and secondary hepatic apudoma. Br J Surg 76:248–249

    Article  CAS  PubMed  Google Scholar 

  5. Ahlman H, Westberg G, Wängberg B, Nilsson O, Tylen U, Schersten T, Tisell LE (1996) Treatment of liver metastases of carcinoid tumors. World J Surg 20:196–202

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Lang, H., Oldhafer, K.J., Schlitt, H.J., Scheumann, G.F.W., Ringe, B., Pichlmayr, R. (1996). Ist die Lebertransplantation als chirurgisches Therapiekonzept bei Metastasen neuroendokriner Tumoren gerechtfertigt?. In: Hartel, W. (eds) Wahrung des Bestandes, Wandel und Fortschritt der Chirurgie. Langenbecks Archiv für Chirurgie, vol 1996. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-80295-9_107

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-80295-9_107

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-61617-7

  • Online ISBN: 978-3-642-80295-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics